Rigel Pharmaceuticals reported $19.89M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acceleron Pharma XLRN:US $ 0M 0M
Acura Pharmaceuticals ACUR:US 601K 5.93M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Amgen AMGN:US $ 37579M 4797M
Anika Therapeutics ANIK:US $ 0M 0M
Applied Genetic Technologies AGTC:US $ 20.1M 0.16M
Arrowhead Research ARWR:US $ 0M 0M
Astrazeneca AZN:US $ 31912M 4417M
AstraZeneca AZN:LN 31912M 4417M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bristol Myers Squibb BMY:US $ 44742M 416M
Celldex Therapeutics CLDX:US $ 0M 0M
Chemocentryx CCXI:US $ 23.57M 0.98M
Daiichi Sankyo 4568:JP Y 163647M 20092M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Flexion Therapeutics FLXN:US $ 250.5M 28.96M
Halozyme Therapeutics HALO:US $ 875.7M 0.97M
Heron Therapeutics HRTX:US $ 149.03M 0.05M
Intrexon XON:US $ 180.17M 2.89M
IONIS PHARMACEUT IONS:US $ 1303M 7.54M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Ligand Pharmaceuticals LGND:US $ 316.93M 1.57M
Macrogenics MGNX:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Rigel Pharmaceuticals RIGL:US $ 19.89M 0.03M
Sangamo Biosciences SGMO:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Veracyte VCYT:US $ 1.08M 0.16M